Clinical Trial Update: Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing lithium to paroxetine in patients with major depressive disorder and a family history of bipolar disorder or suicide was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lithium (Lithium carbonate)
• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Major Depressive Disorder | Phase 3 | Status: TERMINATED